Medical Advocates
Tenofovir 300mg/Emtricitabine 200mg (Truvada)
   
Main Page

New and Noteworthy
FDA Updates
Product Information
Journal Citations
Conference Citations
Pediatric Data
Perinatal Data


 

  
Tenofovir Main Page Main New/Newsworthy Home Page      

This web page is best viewed by using INTERNET EXPLORER
Last Update:  June 03, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
May 2008
 
FDA Updates
     
Pediatric Data
     
USPHS Pediatric Antiretroviral Drug Information
 US Treatment Guidelines
Perinatal Data
 
Guidelines

     United States

          Internet Documents
 
  FULL TEXT PDF DOCUMENT
Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs
in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV  Transmission in the United States.
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines
 
  FULL TEXT PDF DOCUMENT
Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
 Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines
 
 
    Journal Papers, Abstracts, and Commentaries
 
  Single-dose tenofovir and emtricitabine for reduction of viral resistance to
non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum
nevirapine for perinatal HIV prevention: an open-label randomised trial.
 Chi BH, Sinkala M, Mbewe F, et al
 Lancet. 2007 Nov 6;
 Abstract

        Conference Reports, Abstracts, and Posters
 
 
Intrapartum Tenofovir and Emtricitabine Reduces Development of Low-level NNRTI
Resistance following Ingestion of Single-dose Nevirapine for Perinatal HIV Prevention
B Chi, L Frenkel, G Aldrovandi, et al
(15th CROI)
 Abstract

 

Tenofovir Main Page Main New/Newsworthy Home Page      

Tenofovir Disoproxil Fumarate/Emtricitabine  (Truvada)
Main Page